chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 10/4 was positive for COVID-19.  ON 10/12 was diagnosed with COVID Pneumonia.  On 10/18 returned to work and was required to obtain the COVID Vaccine.  Since under 30 days from the onset of COVID-19 Dr. stated unable to receive the first vaccine until 11/4.   On 11/9 went to clinic to receive first dose even still having a cough from the Pneumonia and was document as having the cough and Polycythemia Vera.  It was determined as stated I should be fine and the vaccine administered.  On 11/10 in the early evening discovered a lump the size of an orange under my left arm at the lymph node.  Waited a day to see if it would diminish which it didn't and on 11/12 seek medical advice.  Advice was given to fill out this form, and go to acute care.  Acute care didn't look at lump and made me a phone appointment with a doctor on the next day.
Breakthrough case admission after 2 vaccines ; Moderna 4/29/21 lot# 303a21A;  Moderna 5/26/21 lot# 030A21A
This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received SHINGRIX for prophylaxis. On 26th March 2019, the patient received SHINGRIX. On 26th March 2019, less than a day after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient got SHINGRIX shot and experienced arm sore. The patient asked whether it was fine to take Tylenol or Advil.
was electively admitted secondary to complaints of low back and right leg pain, and underwent a L4 to S1 fusion, interbody device and discectomies, and had significant improvement. Wound is dry and intact. Ambulating on her own. Tolerating p.o. diet. Discharged to home. Hospital admission within 6 weeks of receiving the COVID vaccine.
Around 5pm on 1/26/2021 I started to have muscle pains. I woke up with chills around midnight. Finally got warmed up and then felt extremely hot, but no fevers.  Mild nausea and muscle pains as well. Woke up in the morning with headache, fatigue, muscle pains, and still nausea. Started to feel better that evening and was fine the next day.
Information has been received from a medical assistant referring to a patient of unknown age and gender. No pertinent or historical conditions were reported. On 21-DEC-2015, the patient was vaccinated with expired dose of VAQTA, 50/1.0 U/mL, dose/frequency: the first dose in series/once, intramuscularly (lot # L001627, expiration date 11-NOV-2015). No adverse effects were reported. Additional information has been requested.
This case was reported by a nurse and described the occurrence of spitting in an infant male subject who was vaccinated with ROTARIX (lyophilized formulation, GlaxoSmithKline). On an unspecified date, the subject received unspecified dose of ROTARIX lyophilized formulation (oral). During vaccination with ROTARIX lyophilized formulation, the subject consumed only about a quarter of the vaccine although the total dose of 1 mL was administered and spit otu the rest of the vaccine which led to an underdose. At the time of reporting the outcome of the event was unspecified.
Patient was admitted on 3/10 as inpatient for encephalopathy, pneumonia, COPD exacerbation. Neurology is consulted and following.  patient recenctly diagnosed with COVID on 2/26/2023.
admitted to hospital with COVID after being vaccinated.  Mostly DI related symptoms. Discharged home after 6 day stay
3/5/21 7:59 AM  Got vaccine Covid-19 Monday-into 5 days have severe headache- nausea - sweats-Chills -no taste no smell  - mild fever-itching- fatigue- diarrhea Arm still puffy like pop-eye, redness gone down on injection site. One welt - popped , scab formed.  No all over body rash unlike past reactions. I should refer to you with any questions.
Day 10 - papular rash on neck & chest. Day 11 - rash (vesicles) on chest, back and neck.
Patient had her first Moderna vaccine today and within about 19 minutes she started to feel tingling in her feet and face(more on right side) and mouth and head some delay/slow speech. She had noticeable facial flushing on her cheeks and forehead.   Patient is scared of needles and brought her dad with her today for support. She was very anxious and tearful with the symptoms she was having.   She denies any itching, hives, throat or tongue swelling not cough or clearing of throat. Patient was placed in supine position BP noted to be elevated. She was given some juice and crackers and tolerating this well. DOD Dr was notified we will be observing her in the tx center.   Patient feeling better after about 45 minutes after her injection.   At 4:33 she c/o her right eye itching but feeling better overall(Dr notified). She is sitting up, drank all her apple juice and crackers, speaking clearly in full sentences.  Reviewed again with Dr. Patient advised to f/u with her primary care provider about her reaction, plan for next dose and f.y elevated BP.  PCP MD: Clinic   Clinic closed I will have to call tomorrow.   Patient left in stable condition with her father, She will call her provider line/CNS if she has any concerns tonight. She will go home and rest the next couple of days. I will try and fax over notes to her PCP and VARES report.
Received anthrax #4 late July 2003 while deployed. Within 48 hrs developed severe headache associated with nausea, no emesis, + photophobia, + phonophobia. Never had a headache like this before. Pain over her entire head. No weakness, no altered sensation, no other visual problems reported. Went to the med clinic and was given Imitrex which made her feel worse. Was then given Toradol and Phenergan with 24 hrs of quarters. After sleeping for 12 hrs she felt better, but was not pain free. Was able to function but required 4000 mg/day of ibuprofen to do so.   After a couple of days, returned to clinic and was given a script for po Toradol and Phenergan and was scheduled for medivac on Aug 5 for further evaluation and MRI. Pt had a prior prolactonoma that medic was concerned about. While in transit, developed sharp stabbing pain, like a constant poking on the back rt side of head that radiates to the front. Also at around that time developed tremors involving upper body and noting problems holding things. Tremors not constant but would last hours at a time and would cease for about 30 minutes before resuming again. Only slept about 4-6 hrs/night and that the tremors did not wake her up. Stated she was so exhausted that nothing woke her up.  Also noted problems with dizziness and memory loss. Stated she had problems walking and was bumping into things. In regards to her memory stated that people would show up for appointments that she did not remember scheduling. She did not realize she had a problem but other people around her did.  Arrived on Aug 18, had her scan and was told all was ok. The neurologist told her that he could not find anything wrong and that this was due to PTSD. Gave her some meds to calm her down.  Currently, patient states she became pregnant in Aug. Headaches are constant and require 1 gm of Tylenol 4-5 times a day. Tremors are now rare and occur approx 2-3 times per wk. Stated that about 2 months ago that the rt side of her face would become numb when she gets the sharp stabbing pain in her head.
The client was given the Moderna COVID vaccine on 02/12/2021, having signed a consent form attesting to (and also verbally attesting to) the fact that she had never received a COVID vaccine. When the vaccine was being entered into Immpact it showed that the client had received a Pfizer COVID vaccine on 02/01/2021. When asked, the client continues to not remember receiving the Pfizer vaccine. The client reports feeling fine and, other than a sore arm, is not experiencing any adverse reactions to either vaccine. Her PCP was notified via phone, as well.
Administered a Bivalent 12+ Covid booster to an 11-year-old
Pfizer COVID-19 Vaccine EUA 12/2/2021 5 PM B/P 144/90, Pulse 92, Respirations 18 Regular, pulse oximetry 98% 5:10 PM B/P 140/88, Pulse 120, Respirations16 Regular, pulse oximetry 98% 5:15 PM B/P 128/80, Pulse 138, Respirations 12 Regular, pulse oximetry 86%-98% 12/2/21 5 PM Per EMT in Vaccine Monitoring area, patient alert and oriented times four, complained of near syncope, history of near syncope with blood draws, 27 weeks pregnant, no known complications with first pregnancy, reports bouts of hypotension during office visits, eating, drinking and answering questions normally, patient reports near syncopal episode with past three vaccinations, no complications with first and second doses of Pfizer COVID-19 vaccine, 5:12 PM began to seize, EMS summoned via 911, airway patent, vital signs monitored, pulse rate tachycardia, O2 saturations dropped into mid 80's, patient began to vomit, patient placed in right recumbent position, O2 administered via nasal cannula at 6 liters per minute, cleared vomitus from mouth area to prevent aspiration, O2 saturation rose to upper 90's, discontinued O2 after a few minutes when patient regained consciousness, O2 saturation remained in upper 90's on room air, patient postictal, EMS arrived, report given with patient pedigree, vitals and emergency contacts, patient transferred to EMS for transport to Medical Center.
Development of thrombus in greater saphernous vein, initially distal, within 1 week moved proximally to proximal greater sapherenous vein.
I had no AE to the vaccine, but early in the morning on 9/14 I developed a scratchy, dry cough which went to pressure on the eyes and a very bad headache. I developed chills and a fever. Lost of taste and smell and congestion. I also developed extreme fatigue and was extremely tired. The next day on 9/15 I tested positive for COVID-19. Still to date I am still having the headaches, the couch is still here, my taste and smell comes and goes and I am still a little fatigued, but no fever. 9/18 I got a regenerome infusion which did make a lot of the congestion and mucus loosen up and I began to feel a little better.
p/vax pt c/o pain in all joints which started about 1wk p/vax;pt states pain is most noticeable in knees & elbows but moves around & is ongoing;postponed vax until saw MD;MD felt had an allergy to vax;
6-7hr p/vax pt found gagging, cyanotic & limp in crib;pt turned pale as soon as mom picked pt up;pt rushed to MD office & found to be nl;
6m month old received an HPV vaccine instead of Prevnar. Patient remained in office for over hour and a half with no reaction at injection site. We called health department and the Manufacturer of the vaccine. They advised us there is no clinical data for this age and to just watch for any type of adverse reactions.
This is a spontaneous report from a contactable physician via Pfizer sales representative. A 10-year-old patient of an unspecified gender received PREVNAR 13, via an unspecified route of administration at single dose on an unspecified date to for immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced recurring ear infections, allergist checked PREVNAR 13 titers, which came back low. The outcome of the events was unknown. The allergist recommended a booster of PREVNAR 13 and rechecking the titers in four weeks. The information on the lot number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with pneumococcal 13-valent conjugate vaccine in this patient cannot be completely excluded.
Hives, started on head, ears, covered entire body. Hives first noted approx. 3 hours after vaccine given. No respiratory distress or other symptoms, resolved by next day
2 days (on 11/9/21) after Moderna COVID booster (my original vaccine was Pfizer) I developed a red rash at the injection site and it continues today. It is warm, slightly raised,  minor itchiness, and about 2?x3?. Via internet I?ve self diagnosed it as ?COVID arm? and understand it is not serious.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Mar2021 as DOSE 1, SINGLE (lot number: EN6208); on 14Apr2021 as DOSE 2, SINGLE (lot number: ER8729); on 17Aug2021 as DOSE 3 (BOOSTER), SINGLE (lot number: FD8448); on 14Jan2022 as DOSE 4 (BOOSTER), SINGLE (lot number: FJ1614); and on 20May2022 as DOSE 5 (BOOSTER), SINGLE (lot number: FM9992) at the age of 35 years for COVID-19 immunization. The patient's relevant medical history included: "Psoriatic arthritis" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing). Concomitant medications included: ADDERALL and TYLENOL. Past drug history included: Amoxicillin, reaction: "Allergy"; Ceclor, reaction: "Allergy." The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: COVID-19 test (SARS-CoV-2 test): result not reported, notes: "Treatment of COVID-19." Therapeutic measures were taken as a result of Vaccination failure, Covid-19 which included Paxlovid taken from 06Aug2022 to 11Aug2022.
A report was received from a health care professional concerning a female vaccinee in her 40s who experienced a shortness of breath hours after receiving 0.5ml Fluvirin on 28Oct02. On 28Oct02 the vaccinee experienced shortness of breath more than 20 minutes after vaccination with 0.5ml Fluvirin IM. The vaccinee was seen in an urgent care clinic and then transferred to the ER of an unspecified hospital. Details of the ER visit were not reported. On 29Oct the vaccinee was reported to be fine and her condition resolved without sequelae. The reporter has assessed the relationship of the vaccine to the event as unclassifiable.
This spontaneous report as received from a other health professional refers to a 12 month old patient. On 08-AUG-2014 the patient was vaccinated with M-M-R II (lot # H011885, expiration date: 25-JUN-2014) 0.5 ml, subcutaneously, which was expired. This is one of several reports received from the same source. Additional information has been requested.
My left upper arm turned dark brown in the area where the shot was about 2 to 3 inches wide.
Rigors, hands and feet felt frozen Temp spikes up to 103.7 lasted 2 days
I have Ehlers-Danlos syndrome. I received my second Pfizer injection for COVID-19 on 4/6/2021. In either late May or June 2021, I noticed that my symptoms were aggravated. There was a significant increase in the level of joint inflammation throughout my body.
Felt light headed and Nervous.  Remained in observation and relaxed for 30 minutes.   After 3 minutes felt fine.
No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 20-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.).    Concomitant medications details were not reported by the reporter. It was reported that 60 doses received to several patient from Lot AS7148B. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment details were not reported by the reporter.
1130 pm day of vaccines. Child put to bed at 8 pm. Odd cry at 11:30pm-found to be very hot, took from bed and undressed, within 30 seconds had tonic/clonic sz 60-90 sec. 30 min postseizure
patient felt pressure and warmth across upper body within 15 min of injection, she complained of some facial swelling, benadryl po given at site, BP monitored after 30 min observation period patient was transported to ED for facial and tongue swelling after injection
no additional AE reported; expired dose of VARlVAX was administered to two patients.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies, drug reactions, allergies or medical history provided.   On 27-JUL-2021, the patient was vaccinated with expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # S022757, expiration date 22-JUL-2021, 1 time dose (exact dose and route of administration were not provided) for prophylaxis. No additional adverse event was reported.
1 day after - soreness at injection site when touched 2 days after - soreness gone and for the next week seemed fine 7 days after - felt overall "off" 8 days after - raised rash at the injection site  about 1 inch wide, still felt off and sluggish. No fever 10 days after - non raised rash that spread to about 3-4 inches wide at injection site, nausea, dizziness. No fever.  This has lasted from day 8-13 (current day) but has lessened towards days 12 & 13
Information has been received from a female physician who in 1993 was vaccinated with RECOMBIVAX HB series. Recently the titer draw showed she failed to seroconvert. The physician also stated she would probably get a "booster" dose of RECOMBIVAX HB. At the time of the report, the patient's status was unknown. Additional information is not expected.
T12 distribution erythematous rash present in right low back/flank, wraps around side to RLQ region. Appears as vesicles that have ruptured, non-tender, no streaking, no exudate, no other sings of infection or trauma. Started valcyclovir 1000 mg TID x 7 days. Started lidocaine ointment 5% x 7 days.
Urticaria arms and trunk started 6/21/2008 Exam by FM 6/26/08
Heart arrythmia, Syncope, Seizure. Admitted through ED. Stress Test, 3 days telemetry monitoring, Echocardiogram, All normal. 12/12/06 Received medical records from hospital which reveal patient admitted 5/8/06-5/10/06 s/p syncopy & possible seizure following vax.  Patient was incontinent of urine & had post ictal period.  Found to be in atrial fib & was admitted to cardio to r/o MI which was ruled out by enzymes.  Instructed not to receive further anthrax vax. Final Dx: Syncope.
Temperature excursion; No further AE details; HCP called to report an expired dose of VARIVAX was administered to Multiple patients. Patient Demographics provided for all patients, please see notes for additional case numbers. HCP gave permission to contact. No symptoms reported. No further AE d; This spontaneous report was received from Pharmacist and refers to a 22-month-old patient of unknown gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 08-JUN-2023, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5ml/once, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided).  On 02-MAR-2023, there was excursion temperature (70 F) for 9 minutes. On 08-JUN-2023, the patient experienced HCP called to report an expired dose of VARIVAX was administered to Multiple patients. Patient Demographics provided for all patients, please see notes for additional case numbers. HCP gave permission to contact. No symptoms reported. No further AE details/No PQC.   Lot Number W0252273 is NOT valid for V210 and does not match any Company product.; Sender's Comments:  US-009507513-2306USA007905: US-009507513-2306USA007917: US-009507513-2306USA008590: US-009507513-2306USA008606: US-009507513-2306USA008760: US-009507513-2306USA008746: US-009507513-2306USA008802: US-009507513-2306USA008772: US-009507513-2306USA008793:
p/recv vax pt fever 103, 1 day; skin lesions, 3day (then scabbed over); cough, 2weeks
NOT HAD A FEVER BLISTER SINCE RECEIVING VACCINE; This spontaneous report received from a patient concerned a 68 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: cold sore, and other pre-existing medical conditions included: The only thing that helps is L-Lysine and diet, avoiding L-Arginine. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included lysine for cold sore. On an unspecified date, the patient experienced not had a fever blister since receiving vaccine (dose number in series 1). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of not had a fever blister since receiving vaccine was not reported. This report was non-serious. This case, involving the same patient is linked to 20220100902 (dose number in series 2).
Nose bleed immediately after receiving nasal presentation H1N1. Stopped after 10-15 minutes.
Thrombocytopenia - platelet count 7.7K. No previous thrombocytopenia in past 6 mos prior to immunization.  Required IVIG infusion to increase PLT ct.
Information has been received from a medical assistant concerning a 2 month old breastfed patient who was vaccinated with a dose of Rotateq.  Subsequently the patient experienced projectile vomiting.  It was unknown whether medical attention was sought.  The patient's outcome was unknown.  This is one of several reports from the same source.  Additional information has been requested.
After 20 mins post injection became dizzy, but episode passed after a "couple" of mins. 10-15 mins later dizziness return and she became hot and shaky. Had her take some ice chips and lay down.
In AM: Post vaccination: dizzy, dimming vision, nausea. Recovered in clinic: In P.M: Client experienced loss of vision, loss of muscle control, swelling to the face, inability to blink. Taken to ER. Kept over night.  2/2/09 Received hospital medical records of 1/22-1/23/09. FINAL DX: painless vision loss, resolved Records reveal patient experienced dizziness, nausea, vomiting, numbness, tingling, facial swelling, transient loss of vision, passed out.  Held in ER overnight for observation.  Ophtho consult done, was WNL & suggested vasovagal reaction to vaccine.